Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer

PURPOSE: Growing numbers of clinical trials test the efficacy of radiotherapy (RT) plus immune checkpoint inhibitors (ICIs), but the number of irradiated sites is not uniform. We aimed to evaluate the efficacy of single-site RT plus immunotherapy in oligometastatic non-small cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peiliang, Yin, Tianwen, Zhao, Kaikai, Yu, Jinming, Teng, Feifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015982/
https://www.ncbi.nlm.nih.gov/pubmed/34812931
http://dx.doi.org/10.1007/s00432-021-03849-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015982/
https://www.ncbi.nlm.nih.gov/pubmed/34812931
http://dx.doi.org/10.1007/s00432-021-03849-3

Ejemplares similares